|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-2-12
|
|
pubmed:abstractText |
The purpose of this study was to investigate whether stent-based delivery of an inhibitor of mammalian target of rapamycin (mTOR) can selectively clear macrophages in rabbit atherosclerotic plaques.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1558-3597
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
13
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
706-15
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17291937-Animals,
pubmed-meshheading:17291937-Atherosclerosis,
pubmed-meshheading:17291937-Autophagy,
pubmed-meshheading:17291937-Cell Line,
pubmed-meshheading:17291937-Drug Delivery Systems,
pubmed-meshheading:17291937-Gene Silencing,
pubmed-meshheading:17291937-Immunosuppressive Agents,
pubmed-meshheading:17291937-Macrophages,
pubmed-meshheading:17291937-Protein Kinases,
pubmed-meshheading:17291937-Rabbits,
pubmed-meshheading:17291937-Sirolimus,
pubmed-meshheading:17291937-Stents,
pubmed-meshheading:17291937-TOR Serine-Threonine Kinases
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Selective clearance of macrophages in atherosclerotic plaques by autophagy.
|
|
pubmed:affiliation |
Antwerp Cardiovascular Institute Middelheim, Antwerp, Belgium. stefan.verheye@pandora.be
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
